UPC APP 58035/2024

Oct 24, 2024·EP4201327 Unitary patent · FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Case details: Status
Written Phase (Claim dismissed)
Action
Generic
Category
Costs assessments
Parties: Claimants
Insulet CorporationOperating co.
Representatives
Marc Grunwald-Peterreins Schley
Respondents
A. Menarini Diagnostics s.r.l.Operating co.
Representatives
Christopher Maierhöfer-Bird & Bird LLP
Martin Kohler-Hoyng Rokh Monegier
Division: Milan LD
Judges: Pierluigi Perrotti
Alima Zana
Anna-Lena Klein
Uwe Schwengelbeck
Technology: Instruments
Medical technology
Language: English
First decided: Dec 30, 2024
EPO Opposition: EOFlow Co., Ltd.Withdrawn2025-03-18
KELLER SCHNEIDER PATENTANWALTS GMBHAdmissible2025-03-19
Inspicos P/SWithdrawn2025-03-19

How this compares

How long the court takes to reach a first decision.

	Median days to first decision
All UPC	124
Milan LD	Locked
Judge Pierluigi Perrotti	Locked
Judge Alima Zana	Locked
Judge Anna-Lena Klein	Locked
Judge Uwe Schwengelbeck	Locked

At the UPC: Insulet Corporation (25 cases)·A. Menarini Diagnostics s.r.l. (16 cases)

Start 14-day free trialAlready a user? Sign in

Related cases

All proceedings on this patent

This dispute contains 5 other proceedings

UPC APP 67784/2024·UPC CFI 793/2024·UPC CoA 769/2024·UPC CFI 400/2024·UPC APP 40442/2024

11 other defendants litigating the same or a related patent

UPC CFI 1230/2026·UPC CoA 34/2026·UPC CoA 930/2025·UPC CFI 773/2025·UPC CoA 194/2025 and 6 more

Start a free trial to see how each one ended.

More cases: Milan LD·2024

Decisions

2024-12-30
Public
Summary: Milan Local Division dismissed Insulet Corporation's application for a cost decision following the rejection of EOFLOW Co. Ltd.'s intervention request in PI proceedings (EP 4 201 327). The court found the application inadmissible: a cost decision under R. 150 RoP requires a prior decision on costs in principle under R. 118.5 RoP. The order rejecting the intervention (1 October 2024) contained no such costs-in-principle decision, so the cost-determination application lacked the prerequisite under R. 156(e) RoP. Insulet was invited to resubmit once a costs award decision was obtained.
Show the legal issues (2)
- Prerequisite of costs-in-principle decision for cost determination application (R. 150, 156 RoP)
- Cost decision following rejection of intervention request

Documents

Document title	Date	Public
Headnote-and-Keywords	2025-01-08	Not public
Outcome of the Order	2024-12-30	Not public
finale order 30 December 2024	2024-12-30	Public
rule 152 ROP	2024-11-11	Not public
Receipt	2024-10-24	Not public
Application for Cost Decision	2024-10-24	Not public
Exhibit PS-C01	2024-10-24	Not public